These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Netilmicin 200 mg twice a day for adult patients with life-threatening infections. A preliminary report.
    Author: Perera MR, Amirak ID, Noone P.
    Journal: Scand J Infect Dis Suppl; 1980; Suppl 23():186-8. PubMed ID: 6937966.
    Abstract:
    The efficacy and toxicity of netilmicin was assessed in 15 patients with life-threatening infections, including six with septicaemia. Fourteen patients were cured with no recurrence of infection. The initial dosage of netilmicin was 200 mg twice a day (2.3-4.0 mg/kg/dose), but subsequent adjustment of dosage was made according to the results of serum assay, either to avoid accumulation or to improve therapeutic response. Probable nephrotoxicity occurred in only one patient and there was no evidence of ototoxicity in the twelve patients who could be assessed.
    [Abstract] [Full Text] [Related] [New Search]